Published in Cell Adh Migr on October 06, 2011
Promotion of remyelination by adipose mesenchymal stem cell transplantation in a cuprizone model of multiple sclerosis. Cell J (2013) 0.81
Immunosuppressive potential of human amnion epithelial cells in the treatment of experimental autoimmune encephalomyelitis. J Neuroinflammation (2015) 0.78
Nogo-receptor 1 deficiency has no influence on immune cell repertoire or function during experimental autoimmune encephalomyelitis. PLoS One (2013) 0.76
'Green mice' as a source of ubiquitous green cells. FEBS Lett (1997) 17.06
Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med (2000) 11.35
Muscle regeneration by bone marrow-derived myogenic progenitors. Science (1998) 10.66
Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A (2001) 7.19
Glial inhibition of CNS axon regeneration. Nat Rev Neurosci (2006) 6.91
From marrow to brain: expression of neuronal phenotypes in adult mice. Science (2000) 6.53
Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature (2003) 6.35
Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci U S A (1997) 3.59
Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol (2001) 3.04
Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol (2003) 3.02
Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study. Lancet Neurol (2009) 2.48
Extensive fusion of haematopoietic cells with Purkinje neurons in response to chronic inflammation. Nat Cell Biol (2008) 2.30
Contribution of transplanted bone marrow cells to Purkinje neurons in human adult brains. Proc Natl Acad Sci U S A (2003) 1.99
Bone marrow-derived cells that populate the adult mouse brain preserve their hematopoietic identity. J Neurosci (2003) 1.96
Plasticity of bone marrow-derived stem cells. Stem Cells (2004) 1.79
Optimized flow cytometric analysis of central nervous system tissue reveals novel functional relationships among cells expressing CD133, CD15, and CD24. Stem Cells (2007) 1.68
Hematopoietic cells maintain hematopoietic fates upon entering the brain. J Exp Med (2005) 1.63
Neogenesis of cerebellar Purkinje neurons from gene-marked bone marrow cells in vivo. J Cell Biol (2001) 1.50
Hemopoietic stem cells with higher hemopoietic potential reside at the bone marrow endosteum. Stem Cells (2007) 1.34
The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination. Nat Neurosci (2004) 1.33
Rare-event analysis in flow cytometry. Clin Lab Med (2007) 1.20
The prospect of stem cells as multi-faceted purveyors of immune modulation, repair and regeneration in multiple sclerosis. Curr Stem Cell Res Ther (2011) 1.02
Multiple sclerosis: a battle between destruction and repair. J Neurochem (2006) 0.99
Myelin repair: the role of stem and precursor cells in multiple sclerosis. Philos Trans R Soc Lond B Biol Sci (2008) 0.93
Isolation of neural stem and precursor cells from rodent tissue. Methods Mol Biol (2008) 0.90
Primordial hematopoietic stem cells generate microglia but not myelin-forming cells in a neural environment. J Neurosci (2003) 0.85
Expression, purification, and encephalitogenicity of recombinant human myelin oligodendrocyte glycoprotein. J Neurochem (1998) 0.84
Impact of polysialylated CD56 on natural killer cell cytotoxicity. BMC Immunol (2007) 0.80
Bone marrow and brain: unexpected allies or accidental acquaintances? Stem Cell Rev (2005) 0.77
Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Nat Biotechnol (2003) 2.80
B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity. Ann Neurol (2010) 2.17
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies. J Exp Med (2013) 1.88
Characterisation and trophic functions of murine embryonic macrophages based upon the use of a Csf1r-EGFP transgene reporter. Dev Biol (2007) 1.61
The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination. Nat Neurosci (2004) 1.33
Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene. Mol Ther (2007) 1.29
The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis. Proc Natl Acad Sci U S A (2003) 1.24
Hematopoietic stem cells reduce postischemic inflammation and ameliorate ischemic brain injury. Stroke (2008) 1.20
CCL2 and CCL5 mediate leukocyte adhesion in experimental autoimmune encephalomyelitis--an intravital microscopy study. J Neuroimmunol (2005) 1.18
Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis. Glia (2005) 1.10
Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination. Cell Transplant (2012) 1.05
Gender does not influence the susceptibility of C57BL/6 mice to develop chronic experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein. Immunol Lett (2002) 1.05
Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOG. J Neuroimmune Pharmacol (2009) 1.03
The prospect of stem cells as multi-faceted purveyors of immune modulation, repair and regeneration in multiple sclerosis. Curr Stem Cell Res Ther (2011) 1.02
Modular transcriptional activity characterizes the initiation and progression of autoimmune encephalomyelitis. J Immunol (2005) 1.01
Regulatory role of p53 in experimental autoimmune encephalomyelitis. J Neuroimmunol (2003) 1.00
Neural differentiation of patient specific iPS cells as a novel approach to study the pathophysiology of multiple sclerosis. Stem Cell Res (2011) 1.00
TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L suppresses experimental autoimmune encephalomyelitis in mice. Immunol Cell Biol (2005) 1.00
Multiple sclerosis: a battle between destruction and repair. J Neurochem (2006) 0.99
B-cell very late antigen-4 deficiency reduces leukocyte recruitment and susceptibility to central nervous system autoimmunity. Ann Neurol (2015) 0.98
Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation. Brain (2012) 0.98
A BAFF antagonist suppresses experimental autoimmune encephalomyelitis by targeting cell-mediated and humoral immune responses. Int Immunol (2006) 0.95
Transplantation of bone marrow transduced to express self-antigen establishes deletional tolerance and permanently remits autoimmune disease. J Immunol (2008) 0.94
The suppression of T cell apoptosis influences the severity of disease during the chronic phase but not the recovery from the acute phase of experimental autoimmune encephalomyelitis in mice. J Neuroimmunol (2002) 0.91
Increased transcriptional activity of milk-related genes following the active phase of experimental autoimmune encephalomyelitis and multiple sclerosis. J Immunol (2007) 0.91
A consensus statement addressing mesenchymal stem cell transplantation for multiple sclerosis: it's time! Stem Cell Rev (2010) 0.90
The application of Fourier transform infrared microspectroscopy for the study of diseased central nervous system tissue. Neuroimage (2011) 0.88
Early glial responses in murine models of multiple sclerosis. Neurochem Int (2004) 0.87
Discovery, optimization, and pharmacological characterization of novel heteroaroylphenylureas antagonists of C-C chemokine ligand 2 function. J Med Chem (2011) 0.87
Early detection of the chemical changes occurring during the induction and prevention of autoimmune-mediated demyelination detected by FT-IR imaging. Neuroimage (2009) 0.86
The magnitude and encephalogenic potential of autoimmune response to MOG is enhanced in MOG deficient mice. J Autoimmun (2003) 0.86
The promise of stem cell and regenerative therapies for multiple sclerosis. J Autoimmun (2008) 0.86
Early intervention with gene-modified mesenchymal stem cells overexpressing interleukin-4 enhances anti-inflammatory responses and functional recovery in experimental autoimmune demyelination. Cell Adh Migr (2012) 0.86
Novel therapeutic targets for axonal degeneration in multiple sclerosis. J Neuropathol Exp Neurol (2010) 0.85
Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls. J Neuroimmunol (2003) 0.84
Comparative study on the therapeutic potential of neurally differentiated stem cells in a mouse model of multiple sclerosis. PLoS One (2012) 0.84
IL-5-deficient mice are susceptible to experimental autoimmune encephalomyelitis. Int Immunol (2003) 0.84
Microglial cystatin F expression is a sensitive indicator for ongoing demyelination with concurrent remyelination. J Neurosci Res (2011) 0.84
Human adipose-derived mesenchymal stem cells engineered to secrete IL-10 inhibit APC function and limit CNS autoimmunity. Brain Behav Immun (2013) 0.83
Quantitative proteome profiling of CNS-infiltrating autoreactive CD4+ cells reveals selective changes during experimental autoimmune encephalomyelitis. J Proteome Res (2014) 0.80
A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells. J Gene Med (2007) 0.79
Lithium chloride improves the efficiency of induced pluripotent stem cell-derived neurospheres. Biol Chem (2015) 0.78
A novel unbiased proteomic approach to detect the reactivity of cerebrospinal fluid in neurological diseases. Mol Cell Proteomics (2011) 0.77
Nogo-receptor 1 deficiency has no influence on immune cell repertoire or function during experimental autoimmune encephalomyelitis. PLoS One (2013) 0.76